For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241105:nRSE8971Ka&default-theme=true
RNS Number : 8971K Spire Healthcare Group PLC 05 November 2024
5 November 2024
Spire Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the "Company") announces that, in accordance with
the terms of its share buyback programme announced on 31 October 2024 (the
"Share Buyback Programme") and the authority granted by its shareholders at
the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased
the following number of its ordinary shares of 1 pence each ("Shares") on the
London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):
Date of purchase: 4 November 2024
Number of Shares purchased: 50,000
Highest price paid per Share (GBp): 221.50
Lowest price paid per Share (GBp): 218.50
Volume weighted average price paid per Share (GBp): 220.5045
Broker: Deutsche Numis
Trading venue: London Stock Exchange
The purchased Shares will be cancelled.
Following the purchase of these Shares, the remaining number of Shares in
issue will be 404,038,352. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is 404,038,352.
This figure may be used by shareholders as the denominator for the calculation
by which they can determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms
part of domestic law of the United Kingdom by virtue of the European Union
(Withdrawal) Act 2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share Buyback
Programme:
Date of purchase Number of ordinary shares purchased Transaction price (GBp share) Time of transaction (UK Time) Transaction reference number Trading venue
4 November 2024 1586 220.50 08:36:51 00072200832TRLO0 XLON
4 November 2024 771 220.50 08:36:51 00072200831TRLO0 XLON
4 November 2024 2016 221.00 08:47:13 00072201138TRLO0 XLON
4 November 2024 1646 221.00 08:47:13 00072201139TRLO0 XLON
4 November 2024 40 221.00 08:47:13 00072201140TRLO0 XLON
4 November 2024 264 221.00 08:47:13 00072201141TRLO0 XLON
4 November 2024 472 221.00 09:01:17 00072201508TRLO0 XLON
4 November 2024 25000 220.75 09:01:37 00072201527TRLO0 XLON
4 November 2024 434 220.00 10:44:56 00072204405TRLO0 XLON
4 November 2024 127 220.00 10:44:56 00072204406TRLO0 XLON
4 November 2024 127 220.00 10:44:56 00072204407TRLO0 XLON
4 November 2024 1556 220.00 10:44:56 00072204408TRLO0 XLON
4 November 2024 222 221.50 10:54:07 00072204669TRLO0 XLON
4 November 2024 850 221.50 10:54:07 00072204670TRLO0 XLON
4 November 2024 973 221.50 10:55:47 00072204731TRLO0 XLON
4 November 2024 923 221.50 11:05:10 00072205036TRLO0 XLON
4 November 2024 343 221.50 11:05:10 00072205037TRLO0 XLON
4 November 2024 320 221.50 11:05:10 00072205038TRLO0 XLON
4 November 2024 2360 221.50 11:10:43 00072205174TRLO0 XLON
4 November 2024 87 220.00 13:11:18 00072207817TRLO0 XLON
4 November 2024 1875 220.00 13:11:18 00072207818TRLO0 XLON
4 November 2024 2259 219.00 14:20:54 00072210063TRLO0 XLON
4 November 2024 1099 219.00 15:20:54 00072212396TRLO0 XLON
4 November 2024 144 219.00 15:20:54 00072212397TRLO0 XLON
4 November 2024 200 219.00 15:20:54 00072212398TRLO0 XLON
4 November 2024 1017 219.00 15:32:47 00072212761TRLO0 XLON
4 November 2024 62 219.00 15:32:47 00072212762TRLO0 XLON
4 November 2024 1223 219.00 15:53:28 00072213471TRLO0 XLON
4 November 2024 135 219.00 15:53:28 00072213472TRLO0 XLON
4 November 2024 1371 219.00 16:02:28 00072213866TRLO0 XLON
4 November 2024 140 219.00 16:02:28 00072213867TRLO0 XLON
4 November 2024 117 219.00 16:02:28 00072213868TRLO0 XLON
4 November 2024 71 218.50 16:05:01 00072213977TRLO0 XLON
4 November 2024 170 218.50 16:05:01 00072213978TRLO0 XLON
This announcement will also be available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra, CFO
+44 (0)7881 672 365
Instinctif Partners
Julian
Walker
+44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSBZLLBZFLFFBE